1/2 Cross modal integration of molecular and physiological networks in ASD
1/2 自闭症谱系障碍中分子和生理网络的跨模态整合
基本信息
- 批准号:9757836
- 负责人:
- 金额:$ 106.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-21 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAnimal ModelAreaArray tomographyAstrocytesAutopsyBehaviorBiologicalBiological AssayBiological ModelsBiophysicsBrainBrain DiseasesCRISPR/Cas technologyCalciumCellsChromatinCognitive deficitsCollaborationsComplexComputer SimulationDataDevelopmentDisease modelElectric StimulationElectrodesEngineeringEquilibriumFaceFunctional disorderGene ExpressionGene ProteinsGenesGeneticGenetic EngineeringGenetic HeterogeneityGenetic ModelsGenetic RiskGenetic TranscriptionGenetic VariationGenomicsGlutamatesHumanHuman GeneticsImageImpairmentIn VitroIndividualInterneuronsInvestigationLeadLinkMeasuresMental disordersMessenger RNAMethodologyModalityModelingMolecularMorphologyMutationNervous System PhysiologyNeurobiologyNeurogliaNeuronal PlasticityNeuronsOpticsOrganoidsPathway interactionsPatientsPatternPhagocytosisPhenotypePhysicsPhysiologicalPhysiologyPrincipal InvestigatorPropertyProsencephalonRadialRattusResearch PersonnelRiskRodentRodent ModelRoleStem cellsStructureSynapsesSynaptosomesSyndromeSystemTestingTissuesUntranslated RNAWorkautism spectrum disorderbasebiophysical modelcell typedensitydisorder riskexperimental studyfetalflexibilityfunctional genomicsgenetic approachgenetic architecturegenetic associationgenetic risk factorgenetic varianthigh riskhuman diseasehuman modelhuman stem cellsimmunocytochemistryin vitro Modelin vivoin vivo Modelinduced pluripotent stem cellinnovationmigrationmolecular pathologynetwork modelsneurogenesisneuropsychiatric disordernovelnovel strategiesoptogeneticspatch clamppredictive modelingpredictive testprogenitorrelating to nervous systemrisk variantsequence learningsingle cell analysissynaptogenesistheoriesthree dimensional cell culturetranscriptome sequencingvirtual reality
项目摘要
Genetic approaches have been successful in identifying causal genetic factors, both common and rare, that
contribute to risk for autism spectrum disorder (ASD), providing a crucial starting point for mechanistic
neurobiological investigations. However, moving towards an integrated mechanistic understanding of ASD at
a molecular, cellular, and circuit level faces substantial challenges, such as extreme genetic heterogeneity
and the lack of causal frameworks with which to connect different levels of analysis of nervous system
function in model systems or patients. Nearly a decade ago, we reasoned that gene and protein networks
would provide an organizing framework for understanding heterogeneous psychiatric disease genetic risk in a
unified context and inform disease modeling; indeed there is now substantial evidence supporting
convergence of major effect risk genes during mid-fetal cortical development. Furthermore, related functional
genomic studies, including in those with a major gene form of ASD (dup)15q11-13, show shared patterns of
transcriptional and chromatin dysregulation in post-mortem ASD brain, further supporting biological
convergence. Where and how this occurs, and what biological mechanism(s) it reflects is not known. To
address this, we propose an ambitious project that addresses several major challenges in establishing causal
linkages between genetic risk and CNS structure and function in ASD. The work proposed in this multi-PI U01
involves a team of four principal investigators and co-investigators from UCLA and Stanford with the expertise
necessary to perform this work using state of the art methodologies, ranging from developing and
characterizing in vitro models of human brain development, stem cells, physiology, genomics, physics, and
behavior. Through close collaboration, we will develop and analyze in vitro human stem cell based models
that are differentiated from induced pluripotent stem cells and assembled into organized 3D brain cultures
called human forebrain spheroids (hFS). These hFS contain the major cell classes of the developing
forebrain, including progenitors, radial glia, cortical interneurons, glutamatergic neurons, and non-reactive
astrocytes, and form functional synapses. We will model the effects of six major effect ASD risk loci in hFS
with molecular, genomic, and physiological analyses to assess convergence at each level of analysis. We will
also conduct comparisons of physiology using three rodent models based on the same genes modeled in vitro
with the aim of integrating phenotypes to develop predictive models and compare with in vivo rodent models.
We will analyze the relationship of molecular alterations and basic cellular and synaptic features with potential
emergent or dynamic network features in control-derived hFS and compare these features with hFS harboring
ASD risk mutations and test a subset of causal relationships based on network model predictions. Completion
of these aims will lead to a more clear understanding of the power and limitations of model systems and
computational models, while uncovering potential areas of convergence in different genetic forms of ASD.
遗传学方法已经成功地识别了常见和罕见的原因遗传因素
增加自闭症谱系障碍(ASD)的风险,为机械性疾病提供了一个重要的起点
神经生物学研究。然而,要对ASD有一个完整的机制理解,请访问
分子、细胞和电路层面面临着巨大的挑战,例如极端的遗传异质性。
以及缺乏用于连接不同层次的神经系统分析的因果框架
在模型系统或患者中发挥作用。近十年前,我们认为基因和蛋白质网络
将提供一个组织框架,以了解不同类型的精神疾病遗传风险
统一的背景和信息疾病建模;确实,现在有大量证据支持
胎儿中期皮质发育过程中主要效应风险基因的趋同。此外,相关泛函
基因组研究,包括那些具有ASD(DUP)15q11-13主要基因形式的人,显示出共同的模式
死后ASD脑内转录和染色质失调,进一步支持生物学
融合。这种情况在哪里发生,如何发生,以及它反映了什么生物学机制(S),目前尚不清楚。至
为了解决这个问题,我们提出了一个雄心勃勃的项目,解决了在确定因果关系方面的几个主要挑战
ASD的遗传风险与中枢神经系统结构和功能之间的联系。在这个多PI-U01中提出的工作
涉及一个由来自加州大学洛杉矶分校和斯坦福大学的四名首席调查人员和联合调查人员组成的团队,他们具有
有必要使用最先进的方法来执行这项工作,包括开发和
描述人类大脑发育、干细胞、生理学、基因组学、物理学和
行为。通过密切合作,我们将开发和分析基于体外人类干细胞的模型
从诱导的多能干细胞分化并组装成有组织的3D脑培养
被称为人类前脑球体(HFS)。这些HF包含正在开发的
前脑,包括前体细胞、放射状胶质细胞、皮质中间神经元、谷氨酸能神经元和非反应性神经元
星形胶质细胞,形成功能性突触。我们将模拟六个主要影响ASD风险基因座对HFS的影响
使用分子、基因组和生理分析来评估每个分析级别的融合。我们会
利用体外模拟的相同基因,对三种啮齿动物模型进行了生理学比较
目的是整合表型以开发预测模型并与体内啮齿动物模型进行比较。
我们将分析分子变化和基本细胞和突触特征与潜能的关系
控制派生的HFS中的紧急或动态网络特征,并将这些特征与HFS
ASD风险突变,并基于网络模型预测测试因果关系的子集。完成
这些目标将使我们更清楚地理解模型系统的力量和局限性
计算模型,同时揭示了ASD不同遗传形式的潜在收敛区域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL H GESCHWIND其他文献
DANIEL H GESCHWIND的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL H GESCHWIND', 18)}}的其他基金
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
项目 2:H1/H2 单倍型对 FTD 引起的 MAPT 突变驱动的细胞疾病相关表型的影响
- 批准号:
10834336 - 财政年份:2023
- 资助金额:
$ 106.75万 - 项目类别:
UCLA High-Throughput Neuropsychiatric Disorder Phenotyping Center (UCLA HT-NPC)
加州大学洛杉矶分校高通量神经精神疾病表型中心 (UCLA HT-NPC)
- 批准号:
10643541 - 财政年份:2023
- 资助金额:
$ 106.75万 - 项目类别:
Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP
揭示染色体 17q21.31 Tau 单倍型对 FTD 和 PSP 神经变性风险的遗传机制
- 批准号:
10789246 - 财政年份:2023
- 资助金额:
$ 106.75万 - 项目类别:
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
项目 2:H1/H2 单倍型对 FTD 引起的 MAPT 突变驱动的细胞疾病相关表型的影响
- 批准号:
10295518 - 财政年份:2021
- 资助金额:
$ 106.75万 - 项目类别:
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP
揭示染色体 17q21.31 Tau 单倍型对 FTD 和 PSP 神经变性风险的遗传机制
- 批准号:
10902613 - 财政年份:2021
- 资助金额:
$ 106.75万 - 项目类别:
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP
揭示染色体 17q21.31 Tau 单倍型对 FTD 和 PSP 神经变性风险的遗传机制
- 批准号:
10295512 - 财政年份:2021
- 资助金额:
$ 106.75万 - 项目类别:
High-throughput Modeling of Autism Risk Genes using Zebrafish - DIVERSITY SUPPLEMENT
使用斑马鱼对自闭症风险基因进行高通量建模 - 多样性补充
- 批准号:
10818861 - 财政年份:2020
- 资助金额:
$ 106.75万 - 项目类别:
High-throughput modeling of autism risk genes using zebrafish
使用斑马鱼进行自闭症风险基因的高通量建模
- 批准号:
10478187 - 财政年份:2020
- 资助金额:
$ 106.75万 - 项目类别:
High-throughput modeling of autism risk genes using zebrafish
使用斑马鱼进行自闭症风险基因的高通量建模
- 批准号:
10121604 - 财政年份:2020
- 资助金额:
$ 106.75万 - 项目类别:
High-throughput modeling of autism risk genes using zebrafish
使用斑马鱼进行自闭症风险基因的高通量建模
- 批准号:
10264069 - 财政年份:2020
- 资助金额:
$ 106.75万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 106.75万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 106.75万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 106.75万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 106.75万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 106.75万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 106.75万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 106.75万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 106.75万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 106.75万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 106.75万 - 项目类别:
Research Grant














{{item.name}}会员




